Cosentyx® Letter for the consulting physician in case of treatment switch (Dutch)
Download Dutch document
To receive by post, click on the "Add to card" button below
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...
Patient websites and organizations
Belgian Hematology Society (BHS)
The Belgian Hematology Society (BHS) is a...
The importance of early testing and early treatment
To choose a suitable treatment for melanoma it is important to make the right diagnosis as soon as possible and to start treatment. On this page you can read more about the diagnosis for...